Gisela Schwab
CIK 1213140 · Pres, Prod Dev & Med Aff & CMO · last filed 2021-07-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$39.18M
Companies
2
Total Filings
84
Lifetime Open-Market Net
-$36.55M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXEL | Pres, Prod Dev & Med Aff & CMO | 703,958 | $55.65 | $39.18M | -$36.55M | 82 | 2021-07-28 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Director | — | $0.00 | — | $0 | 2 | 2021-07-02 |
Recent Filings · Page 3 of 9
84 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-06 | EXEL | Mixed | +11,565 | -$71.2K | EDGAR |
| 2019-12-05 | EXEL | Mixed | — | -$535.5K | EDGAR |
| 2019-11-15 | EXEL | Tax (F) | −12,268 | -$202.5K | EDGAR |
| 2019-11-06 | EXEL | Mixed | — | -$524.0K | EDGAR |
| 2019-10-03 | EXEL | Mixed | — | -$370.8K | EDGAR |
| 2019-09-13 | EXEL | Mixed | +7,818 | -$49.6K | EDGAR |
| 2019-04-03 | EXEL | Mixed | — | -$1.12M | EDGAR |
| 2019-03-27 | EXEL | Mixed | — | -$1.60M | EDGAR |
| 2019-02-15 | EXEL | Mixed | — | -$1.99M | EDGAR |
| 2018-12-03 | EXEL | Mixed | — | -$215.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.